The store will not work correctly when cookies are disabled.
2-(8-hydroxyquinolin-2-yl)-3-phenylthiazolidin-4-one
ID: ALA4777085
PubChem CID: 162643382
Max Phase: Preclinical
Molecular Formula: C18H14N2O2S
Molecular Weight: 322.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CSC(c2ccc3cccc(O)c3n2)N1c1ccccc1
Standard InChI: InChI=1S/C18H14N2O2S/c21-15-8-4-5-12-9-10-14(19-17(12)15)18-20(16(22)11-23-18)13-6-2-1-3-7-13/h1-10,18,21H,11H2
Standard InChI Key: PSKLAYKWSCSPGF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
11.6085 -10.3634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6073 -11.1830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3154 -11.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3136 -9.9546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0222 -10.3598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0230 -11.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7315 -11.5859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4398 -11.1751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4350 -10.3530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7259 -9.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3173 -12.4091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1532 -11.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2418 -12.3905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0418 -12.5573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4477 -11.8479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8984 -11.2429 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.6383 -12.9371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8595 -12.6860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2547 -13.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4275 -14.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2105 -14.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8119 -13.7322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3771 -13.3025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.39 | Molecular Weight (Monoisotopic): 322.0776 | AlogP: 3.72 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 3.27 | CX LogD: 3.26 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.78 | Np Likeness Score: -0.70 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |